Drugs & Targets Merck to assume full responsibility for Erbitux in Japan from Bristol Myers-Squibb February 13, 2015Vol.41 No.06
Drugs & Targets MPDL3280A receives second breakthrough therapy designation February 06, 2015Vol.41 No.05
Drugs & Targets FDA Grants Accelerated Approval To Ibrance in Breast Cancer February 06, 2015Vol.41 No.05
Drugs & Targets Yondelis granted priority review in advanced soft tissue sarcoma February 06, 2015Vol.41 No.05
